MREO
Mereo BioPharma
MREO
MREO
64 hedge funds and large institutions have $182M invested in Mereo BioPharma in 2023 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 19 increasing their positions, 13 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
14% more funds holding
Funds holding: 56 → 64 (+8)
1.15% more ownership
Funds ownership: 10.06% → 11.21% (+1.2%)
Holders
64
Holding in Top 10
1
Calls
$2.21M
Puts
$107K
Top Buyers
| 1 | +$7.44M | |
| 2 | +$4.47M | |
| 3 | +$4.27M | |
| 4 |
Aberdeen Group
Edinburgh,
United Kingdom
|
+$3.58M |
| 5 |
Alkeon Capital Management
New York
|
+$1.16M |
Top Sellers
| 1 | -$4.43M | |
| 2 | -$655K | |
| 3 | -$428K | |
| 4 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$424K |
| 5 |
JPMorgan Chase & Co
New York
|
-$263K |